Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,157 public trials 307 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

NCT00070083

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
  • Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada
  • British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

NCT00230217

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkley, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

NCT00088101

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +15 more
Locations
  • Wilshire Oncology Medical Group Pomona, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Tufts New England Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions